Skip to content
PubMed This is a summary of 128 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 128 referenced papers

Top Authors

Andrew N Menzies-Gow
AstraZeneca (United Kingdom)
Liam Gabriel Heaney
Queen's University Belfast
David Price
University of Aberdeen
Celeste Michala Porsbjerg
Bispebjerg Hospital
Christopher Edward Brightling
University of Leicester
Guy Brusselle
Ghent University Hospital
Helen Kathryn Reddel
The University of Sydney
Roland Buhl
University Medical Center of the Johannes Gutenberg University Mainz

Top Institutions

Ranked by publications Top 10 institutions
10

Hôpital du Sacré-Cœur de Montréal

Montreal, Canada

16 papers

References

References (128)
  1. 1

    Occupational asthma and work-exacerbated asthma.

    Friedman-Jimenez G, Harrison D, Luo H

    Seminars in respiratory and critical care medicine 2015; (36(3)):388-407 doi:10.1055/s-0035-1550157.

    PMID: 26024347
  2. 2

    An official American Thoracic Society Workshop Report: presentations and discussion of the fifth Jack Pepys Workshop on Asthma in the Workplace. Comparisons between asthma in the workplace and non-work-related asthma.

    Malo JL, Tarlo SM, Sastre J, et al.

    Annals of the American Thoracic Society 2015; (12(7)):S99-S110 doi:10.1513/AnnalsATS.201505-281ST.

    PMID: 26203621
  3. 3

    Assessment of acute asthma severity in the ED: are heart and respiratory rates relevant?

    Rodrigo GJ, Neffen H

    The American journal of emergency medicine 2015; (33(11)):1583-6.

    PMID: 26233619
  4. 4

    Work-Related Asthma.

    Jolly AT, Klees JE, Pacheco KA, et al.

    Journal of occupational and environmental medicine 2015; (57(10)):e121-9 doi:10.1097/JOM.0000000000000572.

    PMID: 26461873
  5. 5

    Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry.

    Sweeney J, Patterson CC, Menzies-Gow A, et al.

    Thorax 2016; (71(4)):339-46 doi:10.1136/thoraxjnl-2015-207630.

    PMID: 26819354
  6. 6

    Do chronic workplace irritant exposures cause asthma?

    Dumas O, Le Moual N

    Current opinion in allergy and clinical immunology 2016; (16(2)):75-85 doi:10.1097/ACI.0000000000000247.

    PMID: 26914673
  7. 7

    Type 2 innate lymphoid cells: at the cross-roads in allergic asthma.

    van Rijt L, von Richthofen H, van Ree R

    Seminars in immunopathology 2016; (38(4)):483-96 doi:10.1007/s00281-016-0556-2.

    PMID: 26965110
  8. 8

    Mitral Stenosis Presenting as Asthma.

    Li S, Jbeli A, Stys M, Stys A

    South Dakota medicine : the journal of the South Dakota State Medical Association 2016; (69(2)):75-7.

    PMID: 26999914
  9. 9

    Severe or life-threatening asthma exacerbation: patient heterogeneity identified by cluster analysis.

    Sekiya K, Nakatani E, Fukutomi Y, et al.

    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2016; (46(8)):1043-55 doi:10.1111/cea.12738.

    PMID: 27041475
  10. 10

    Dose-Response Relationship Between Long-Term Systemic Corticosteroid Use and Related Complications in Patients with Severe Asthma.

    Dalal AA, Duh MS, Gozalo L, et al.

    Journal of managed care & specialty pharmacy 2016; (22(7)):833-47 doi:10.18553/jmcp.2016.22.7.833.

    PMID: 27348284
  11. 11

    Near fatal asthma: treatment and prevention.

    D'Amato G, Vitale C, Lanza M, et al.

    European annals of allergy and clinical immunology 2016; (48(4)):116-22.

    PMID: 27425166
  12. 12

    Occupational Respiratory Allergic Diseases in Healthcare Workers.

    Mazurek JM, Weissman DN

    Current allergy and asthma reports 2016; (16(11)):77 doi:10.1007/s11882-016-0657-y.

    PMID: 27796792
  13. 13

    Occupational asthma: diagnostic challenges and management dilemmas.

    Trivedi V, Apala DR, Iyer VN

    Current opinion in pulmonary medicine 2017; (23(2)):177-183 doi:10.1097/MCP.0000000000000352.

    PMID: 27875341
  14. 14

    Review of Diagnostic Challenges in Occupational Asthma.

    Pralong JA, Cartier A

    Current allergy and asthma reports 2017; (17(1)):1 doi:10.1007/s11882-017-0676-3.

    PMID: 28091866
  15. 15

    A single intervention for cockroach control reduces cockroach exposure and asthma morbidity in children.

    Rabito FA, Carlson JC, He H, et al.

    The Journal of allergy and clinical immunology 2017; (140(2)):565-570 doi:10.1016/j.jaci.2016.10.019.

    PMID: 28108117
  16. 16

    Environmental triggers and avoidance in the management of asthma.

    Gautier C, Charpin D

    Journal of asthma and allergy 2017; (10()):47-56 doi:10.2147/JAA.S121276.

    PMID: 28331347
  17. 17

    The US Food and Drug Administration's drug safety recommendations and long-acting beta2-agonist dispensing pattern changes in adult asthma patients: 2003-2012.

    Zhou EH, Seymour S, Goulding MR, et al.

    Journal of asthma and allergy 2017; (10()):67-74 doi:10.2147/JAA.S124395.

    PMID: 28356763
  18. 18

    American Thoracic Society/National Heart, Lung, and Blood Institute Asthma-Chronic Obstructive Pulmonary Disease Overlap Workshop Report.

    Woodruff PG, van den Berge M, Boucher RC, et al.

    American journal of respiratory and critical care medicine 2017; (196(3)):375-381 doi:10.1164/rccm.201705-0973WS.

    PMID: 28636425
  19. 19

    Assessment of eosinophilic airway inflammation as a contribution to the diagnosis of occupational asthma.

    Beretta C, Rifflart C, Evrard G, et al.

    Allergy 2018; (73(1)):206-213 doi:10.1111/all.13265.

    PMID: 28771844
  20. 20

    [Warning symptoms of asthma attack and asthma self-management: a national asthma control survey from China].

    Lin JT, Wang WQ, Zhou X, et al.

    Zhonghua yi xue za zhi 2017; (97(30)):2329-2332 doi:10.3760/cma.j.issn.0376-2491.2017.30.003.

    PMID: 28822448
  21. 21

    The national burden of poorly controlled asthma, school absence and parental work loss among school-aged children in the United States.

    Sullivan PW, Ghushchyan V, Navaratnam P, et al.

    The Journal of asthma : official journal of the Association for the Care of Asthma 2018; (55(6)):659-667 doi:10.1080/02770903.2017.1350972.

    PMID: 28981368
  22. 22

    Review article: gastro-oesophageal reflux disease in asthma and chronic obstructive pulmonary disease.

    Broers C, Tack J, Pauwels A

    Alimentary pharmacology & therapeutics 2018; (47(2)):176-191 doi:10.1111/apt.14416.

    PMID: 29193245
  23. 23

    Asthma mimic: Case report and literature review of vocal cord nodule associated with wheezing.

    Kashif M, Singh T, Aslam A, Khaja M

    SAGE open medical case reports 2017; (5()):2050313X17744980 doi:10.1177/2050313X17744980.

    PMID: 29230286
  24. 24

    A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma.

    Sulaiman I, Greene G, MacHale E, et al.

    The European respiratory journal 2018; (51(1)) doi:10.1183/13993003.01126-2017.

    PMID: 29301919
  25. 25

    Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed.

    Jacobson GA, Raidal S, Hostrup M, et al.

    Drug safety 2018; (41(5)):441-449 doi:10.1007/s40264-017-0631-1.

    PMID: 29332144
  26. 26

    Symbicort® Maintenance and Reliever Therapy (SMART) and the evolution of asthma management within the GINA guidelines.

    Lin J, Zhou X, Wang C, et al.

    Expert review of respiratory medicine 2018; (12(3)):191-202 doi:10.1080/17476348.2018.1429921.

    PMID: 29400090
  27. 27

    Nebulized Lidocaine as an Alternative Therapy for Reactive Airway Dysfunction Syndrome.

    Özyiğit LP, Erer A, Okumuş G, et al.

    Turkish thoracic journal 2016; (17(2)):82-83 doi:10.5578/ttj.17.2.017.

    PMID: 29404130
  28. 28

    Environmental Causes of Asthma.

    Cockcroft DW

    Seminars in respiratory and critical care medicine 2018; (39(1)):12-18 doi:10.1055/s-0037-1606219.

    PMID: 29427981
  29. 29

    Diagnosis and Management of Severe Asthma.

    Chung KF

    Seminars in respiratory and critical care medicine 2018; (39(1)):91-99 doi:10.1055/s-0037-1607391.

    PMID: 29427989
  30. 30

    Cleaning at Home and at Work in Relation to Lung Function Decline and Airway Obstruction.

    Svanes Ø, Bertelsen RJ, Lygre SHL, et al.

    American journal of respiratory and critical care medicine 2018; (197(9)):1157-1163 doi:10.1164/rccm.201706-1311OC.

    PMID: 29451393
  31. 31

    Effectiveness of indoor allergen reduction in asthma management: A systematic review.

    Leas BF, D'Anci KE, Apter AJ, et al.

    The Journal of allergy and clinical immunology 2018; (141(5)):1854-1869 doi:10.1016/j.jaci.2018.02.001.

    PMID: 29452202
  32. 32

    Do laboratory challenge tests for occupational asthma represent what happens in the workplace?

    Burge PS, Moore VC, Robertson AS, Walters GI

    The European respiratory journal 2018; (51(6)) doi:10.1183/13993003.00059-2018.

    PMID: 29748310
  33. 33

    Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma.

    Rabe KF, Nair P, Brusselle G, et al.

    The New England journal of medicine 2018; (378(26)):2475-2485 doi:10.1056/NEJMoa1804093.

    PMID: 29782224
  34. 34

    Medication Regimens for Managing Acute Asthma.

    Maselli DJ, Peters JI

    Respiratory care 2018; (63(6)):783-796 doi:10.4187/respcare.05953.

    PMID: 29794211
  35. 35

    Diagnosis of concomitant inducible laryngeal obstruction and asthma.

    Lee JW, Tay TR, Paddle P, et al.

    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2018; (48(12)):1622-1630 doi:10.1111/cea.13185.

    PMID: 29870077
  36. 36

    Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature.

    Volmer T, Effenberger T, Trautner C, Buhl R

    The European respiratory journal 2018; (52(4)) doi:10.1183/13993003.00703-2018.

    PMID: 30190274
  37. 37

    Remotely Monitored Therapy and Nitric Oxide Suppression Identifies Nonadherence in Severe Asthma.

    Heaney LG, Busby J, Bradding P, et al.

    American journal of respiratory and critical care medicine 2019; (199(4)):454-464 doi:10.1164/rccm.201806-1182OC.

    PMID: 30339770
  38. 38

    Differentiation of adult severe asthma from difficult-to-treat asthma - Outcomes of a systematic assessment protocol.

    von Bülow A, Backer V, Bodtger U, et al.

    Respiratory medicine 2018; (145()):41-47 doi:10.1016/j.rmed.2018.10.020.

    PMID: 30509715
  39. 39

    Update on the Management of Occupational Asthma and Work-Exacerbated Asthma.

    Lau A, Tarlo SM

    Allergy, asthma & immunology research 2019; (11(2)):188-200 doi:10.4168/aair.2019.11.2.188.

    PMID: 30661311
  40. 40

    Occupational asthma and rhinitis: Do we think about it as soon as possible?

    Klusáčková P, Lebedová J

    Casopis lekaru ceskych 2018; (157(8)):406-410.

    PMID: 30754977
  41. 41

    Severe Occupational Asthma: Insights From a Multicenter European Cohort.

    Vandenplas O, Godet J, Hurdubaea L, et al.

    The journal of allergy and clinical immunology. In practice 2019; (7(7)):2309-2318.e4 doi:10.1016/j.jaip.2019.03.017.

    PMID: 30914232
  42. 42

    Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma.

    Katsaounou P, Buhl R, Brusselle G, et al.

    Respiratory medicine 2019; (150()):51-62 doi:10.1016/j.rmed.2019.02.003.

    PMID: 30961951
  43. 43

    Serial fractional exhaled nitric oxide measurements off and at work in the diagnosis of occupational asthma.

    van Kampen V, Brüning T, Merget R

    American journal of industrial medicine 2019; (62(8)):663-671 doi:10.1002/ajim.22996.

    PMID: 31168929
  44. 44

    "Characteristics of patients admitted to emergency department for asthma attack: a real-LIFE study".

    Losappio L, Heffler E, Carpentiere R, et al.

    BMC pulmonary medicine 2019; (19(1)):107 doi:10.1186/s12890-019-0869-8.

    PMID: 31208388
  45. 45

    Viruses and non-allergen environmental triggers in asthma.

    Chau-Etchepare F, Hoerger JL, Kuhn BT, et al.

    Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2019; (67(7)):1029-1041 doi:10.1136/jim-2019-001000.

    PMID: 31352362
  46. 46

    Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management.

    Bleecker ER, Menzies-Gow AN, Price DB, et al.

    American journal of respiratory and critical care medicine 2020; (201(3)):276-293 doi:10.1164/rccm.201904-0903SO.

    PMID: 31525297
  47. 47

    Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline.

    Holguin F, Cardet JC, Chung KF, et al.

    The European respiratory journal 2020; (55(1)) doi:10.1183/13993003.00588-2019.

    PMID: 31558662
  48. 48

    Workplace interventions for treatment of occupational asthma.

    Henneberger PK, Patel JR, de Groene GJ, et al.

    The Cochrane database of systematic reviews 2019; (10()):CD006308 doi:10.1002/14651858.CD006308.pub4.

    PMID: 31593318
  49. 49

    Acute severe asthma (status asthmaticus).

    Agnihotri NT, Saltoun C

    Allergy and asthma proceedings 2019; (40(6)):406-409 doi:10.2500/aap.2019.40.4258.

    PMID: 31690381
  50. 50

    Immunologic mechanisms in asthma.

    Boonpiyathad T, Sözener ZC, Satitsuksanoa P, Akdis CA

    Seminars in immunology 2019; (46()):101333 doi:10.1016/j.smim.2019.101333.

    PMID: 31703832
  51. 51

    Occupational asthma.

    Cormier M, Lemière C

    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2020; (24(1)):8-21 doi:10.5588/ijtld.19.0301.

    PMID: 32005302
  52. 52

    Home Management of Childhood Asthma Exacerbations.

    Yeung TY, Ewing C, Malanowska A, et al.

    Pulmonary therapy 2018; (4(2)):149-157 doi:10.1007/s41030-018-0061-y.

    PMID: 32026392
  53. 53

    Association of use of cleaning products with respiratory health in a Canadian birth cohort.

    Parks J, McCandless L, Dharma C, et al.

    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2020; (192(7)):E154-E161 doi:10.1503/cmaj.190819.

    PMID: 32071106
  54. 54

    Determinants of Acute Asthma Attack among adult asthmatic patients visiting hospitals of Tigray, Ethiopia, 2019: case control study.

    Negash M, Tsegabrhan H, Meles T, et al.

    Asthma research and practice 2020; (6()):1 doi:10.1186/s40733-020-00054-w.

    PMID: 32266074
  55. 55

    Performance Characteristics of Spirometry With Negative Bronchodilator Response and Methacholine Challenge Testing and Implications for Asthma Diagnosis.

    Selvanathan J, Aaron SD, Sykes JR, et al.

    Chest 2020; (158(2)):479-490 doi:10.1016/j.chest.2020.03.052.

    PMID: 32298731
  56. 56

    Update on House Dust Mite Allergen Avoidance Measures for Asthma.

    Zuiani C, Custovic A

    Current allergy and asthma reports 2020; (20(9)):50 doi:10.1007/s11882-020-00948-y.

    PMID: 32561997
  57. 57

    Treatment options in type-2 low asthma.

    Hinks TSC, Levine SJ, Brusselle GG

    The European respiratory journal 2021; (57(1)) doi:10.1183/13993003.00528-2020.

    PMID: 32586877
  58. 58

    Progress in Occupational Asthma.

    Tiotiu AI, Novakova S, Labor M, et al.

    International journal of environmental research and public health 2020; (17(12)) doi:10.3390/ijerph17124553.

    PMID: 32599814
  59. 59

    Work-related asthma: A position paper from the Thoracic Society of Australia and New Zealand and the National Asthma Council Australia.

    Hoy R, Burdon J, Chen L, et al.

    Respirology (Carlton, Vic.) 2020; (25(11)):1183-1192 doi:10.1111/resp.13951.

    PMID: 33020986
  60. 60

    The management of mild asthma.

    O'Byrne PM, Reddel HK, Beasley R

    The European respiratory journal 2021; (57(4)) doi:10.1183/13993003.03051-2020.

    PMID: 33093120
  61. 61

    Novel approaches in occupational asthma diagnosis and management.

    Quirce S, Domínguez-Ortega J, Luna JA

    Current opinion in pulmonary medicine 2021; (27(1)):9-14 doi:10.1097/MCP.0000000000000737.

    PMID: 33141780
  62. 62

    Mechanisms of non-type 2 asthma.

    Hudey SN, Ledford DK, Cardet JC

    Current opinion in immunology 2020; (66()):123-128 doi:10.1016/j.coi.2020.10.002.

    PMID: 33160187
  63. 63

    Assessment and Management of Occupational Asthma.

    Cullinan P, Vandenplas O, Bernstein D

    The journal of allergy and clinical immunology. In practice 2020; (8(10)):3264-3275 doi:10.1016/j.jaip.2020.06.031.

    PMID: 33161958
  64. 64

    Management of Asthma Exacerbations in the Emergency Department.

    Hasegawa K, Craig SS, Teach SJ, Camargo CA

    The journal of allergy and clinical immunology. In practice 2021; (9(7)):2599-2610 doi:10.1016/j.jaip.2020.12.037.

    PMID: 33387672
  65. 65

    Difficult to Treat and Severe Asthma: Management Strategies.

    Narasimhan K

    American family physician 2021; (103(5)):286-290.

    PMID: 33630543
  66. 66

    Pulmonary Function Testing in Work-Related Asthma: An Overview from Spirometry to Specific Inhalation Challenge.

    Poussel M, Thaon I, Penven E, Tiotiu AI

    International journal of environmental research and public health 2021; (18(5)) doi:10.3390/ijerph18052325.

    PMID: 33652998
  67. 67

    Inhalation Challenge Tests in Occupational Asthma: Why Are Multiple Tests Needed?

    Akgündüz Üzmezoğlu B

    Turkish thoracic journal 2021; (22(2)):154-162 doi:10.5152/TurkThoracJ.2021.20007.

    PMID: 33871340
  68. 68

    Occupational Respiratory Allergy: Risk Factors, Diagnosis, and Management.

    Raulf M

    Handbook of experimental pharmacology 2022; (268()):213-225 doi:10.1007/164_2021_472.

    PMID: 34031758
  69. 69

    Is It Really Feasible to Use Budesonide-Formoterol as Needed for Mild Persistent Asthma? A Systematic Review and Meta-Analysis.

    Tong X, Liu T, Li Z, et al.

    Frontiers in pharmacology 2021; (12()):644629 doi:10.3389/fphar.2021.644629.

    PMID: 34149408
  70. 70

    GOLD 2021 Strategy Report: Implications for Asthma-COPD Overlap.

    Roman-Rodriguez M, Kaplan A

    International journal of chronic obstructive pulmonary disease 2021; (16()):1709-1715 doi:10.2147/COPD.S300902.

    PMID: 34163155
  71. 71

    Combination fixed-dose β agonist and steroid inhaler as required for adults or children with mild asthma: a Cochrane systematic review.

    Crossingham I, Turner S, Ramakrishnan S, et al.

    BMJ evidence-based medicine 2022; (27(3)):178-184 doi:10.1136/bmjebm-2021-111764.

    PMID: 34282031
  72. 72

    Work-related asthma.

    Roio LCD, Mizutani RF, Pinto RC, et al.

    Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 2021; (47(4)):e20200577 doi:10.36416/1806-3756/e20200577.

    PMID: 34406224
  73. 73

    Asthma and Comorbid Conditions-Pulmonary Comorbidity.

    Gibson PG, McDonald VM, Granchelli A, Olin JT

    The journal of allergy and clinical immunology. In practice 2021; (9(11)):3868-3875 doi:10.1016/j.jaip.2021.08.028.

    PMID: 34492401
  74. 74

    Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study.

    Menzies-Gow A, Gurnell M, Heaney LG, et al.

    The Lancet. Respiratory medicine 2022; (10(1)):47-58 doi:10.1016/S2213-2600(21)00352-0.

    PMID: 34619104
  75. 75

    Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.

    Reddel HK, Bacharier LB, Bateman ED, et al.

    American journal of respiratory and critical care medicine 2022; (205(1)):17-35 doi:10.1164/rccm.202109-2205PP.

    PMID: 34658302
  76. 76

    A Practical Guide to Implementing SMART in Asthma Management.

    Reddel HK, Bateman ED, Schatz M, et al.

    The journal of allergy and clinical immunology. In practice 2022; (10(1S)):S31-S38 doi:10.1016/j.jaip.2021.10.011.

    PMID: 34666208
  77. 77

    Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.

    Reddel HK, Bacharier LB, Bateman ED, et al.

    Respirology (Carlton, Vic.) 2022; (27(1)):14-35 doi:10.1111/resp.14174.

    PMID: 34668278
  78. 78

    Clinical value of bronchodilator response for diagnosing asthma in steroid-naïve adults.

    Tuomisto LE, Ilmarinen P, Lehtimäki L, et al.

    ERJ open research 2021; (7(4)) doi:10.1183/23120541.00293-2021.

    PMID: 34912880
  79. 79

    Baseline type 2 biomarker levels and response to tezepelumab in severe asthma.

    Corren J, Pham TH, Garcia Gil E, et al.

    Allergy 2022; (77(6)):1786-1796 doi:10.1111/all.15197.

    PMID: 34913186
  80. 80

    TH17 cells and corticosteroid insensitivity in severe asthma.

    Xie Y, Abel PW, Casale TB, Tu Y

    The Journal of allergy and clinical immunology 2022; (149(2)):467-479 doi:10.1016/j.jaci.2021.12.769.

    PMID: 34953791
  81. 81

    European Respiratory Society guidelines for the diagnosis of asthma in adults.

    Louis R, Satia I, Ojanguren I, et al.

    The European respiratory journal 2022; (60(3)) doi:10.1183/13993003.01585-2021.

    PMID: 35169025
  82. 82

    The Impact of Ambient Environmental and Occupational Pollution on Respiratory Diseases.

    Nishida C, Yatera K

    International journal of environmental research and public health 2022; (19(5)) doi:10.3390/ijerph19052788.

    PMID: 35270479
  83. 83

    Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America.

    Quint JK, Arnetorp S, Kocks JWH, et al.

    The journal of allergy and clinical immunology. In practice 2022; (10(9)):2297-2309.e10 doi:10.1016/j.jaip.2022.02.047.

    PMID: 35364341
  84. 84

    Tezepelumab compared with other biologics for the treatment of severe asthma: a systematic review and indirect treatment comparison.

    Menzies-Gow A, Steenkamp J, Singh S, et al.

    Journal of medical economics 2022; (25(1)):679-690 doi:10.1080/13696998.2022.2074195.

    PMID: 35570578
  85. 85

    Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis.

    Wechsler ME, Klion AD, Paggiaro P, et al.

    The journal of allergy and clinical immunology. In practice 2022; (10(10)):2695-2709 doi:10.1016/j.jaip.2022.05.019.

    PMID: 35636689
  86. 86

    Effectiveness of Maintenance and Reliever Therapy Using Inhaled Corticosteroid-Formoterol in Asthmatics.

    Kim C, Lee Y, Lee E, et al.

    The journal of allergy and clinical immunology. In practice 2022; (10(10)):2638-2645.e3 doi:10.1016/j.jaip.2022.06.009.

    PMID: 35752435
  87. 87

    Irritant-Induced Asthma.

    Lemiere C, Lavoie G, Doyen V, Vandenplas O

    The journal of allergy and clinical immunology. In practice 2022; (10(11)):2799-2806 doi:10.1016/j.jaip.2022.06.045.

    PMID: 35820617
  88. 88

    Patients' and physicians' perspectives on the burden and management of asthma: Results from the APPaRENT 2 study.

    Chapman KR, Canonica GW, Lavoie KL, et al.

    Respiratory medicine 2022; (201()):106948 doi:10.1016/j.rmed.2022.106948.

    PMID: 36029695
  89. 89

    Determinants of Asthma Attack Among Adult Asthmatic Patients Attending at Public Hospitals of West Shoa Zone, Oromia Regional State, Ethiopia, 2021: Case-Control Study.

    Megersa S, Chala G, Fikremariam K

    Journal of asthma and allergy 2022; (15()):1143-1154 doi:10.2147/JAA.S376499.

    PMID: 36042713
  90. 90

    Occupational asthma in teachers.

    Burge S, Moore V, Burge C, et al.

    Occupational medicine (Oxford, England) 2022; (72(8)):541-549 doi:10.1093/occmed/kqac087.

    PMID: 36097688
  91. 91

    The efficacy of the Dyson air purifier on asthma control: A single-center, investigator-led, randomized, double-blind, placebo-controlled trial.

    Fong WCG, Kadalayil L, Lowther S, et al.

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2023; (130(2)):199-205.e2 doi:10.1016/j.anai.2022.10.010.

    PMID: 36288782
  92. 92

    Efficacy of tezepelumab in patients with evidence of severe allergic asthma: Results from the phase 3 NAVIGATOR study.

    Corren J, Ambrose CS, Griffiths JM, et al.

    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2023; (53(4)):417-428 doi:10.1111/cea.14256.

    PMID: 36507576
  93. 93

    Impact of occupational asthma on health and employment status: a long-term follow-up study.

    Mason P, Liviero F, Paccagnella ER, et al.

    Occupational and environmental medicine 2023; (80(2)):70-76 doi:10.1136/oemed-2022-108504.

    PMID: 36581454
  94. 94

    Update on irritant-induced occupational asthma.

    Ronsmans S, Le Moual N, Dumas O

    Current opinion in allergy and clinical immunology 2023; (23(2)):63-69 doi:10.1097/ACI.0000000000000884.

    PMID: 36729951
  95. 95

    [Criteria for evaluation of response to biologics in severe asthma - the Biologics Asthma Response Score (BARS)].

    Milger K, Korn S, Feder C, et al.

    Pneumologie (Stuttgart, Germany) 2023; (77(4)):220-232 doi:10.1055/a-2014-4350.

    PMID: 36796422
  96. 96

    Eosinophilic granulomatosis with polyangiitis developed after dupilumab administration in patients with eosinophilic chronic rhinosinusitis and asthma: a case report.

    Suzaki I, Tanaka A, Yanai R, et al.

    BMC pulmonary medicine 2023; (23(1)):130 doi:10.1186/s12890-023-02415-6.

    PMID: 37076824
  97. 97

    T-helper cells and their cytokines in pathogenesis and treatment of asthma.

    Ji T, Li H

    Frontiers in immunology 2023; (14()):1149203 doi:10.3389/fimmu.2023.1149203.

    PMID: 37377958
  98. 98

    Indoor Environmental Exposures and Their Relationship to Allergic Diseases.

    Grant TL, Wood RA, Chapman MD

    The journal of allergy and clinical immunology. In practice 2023; (11(10)):2963-2970 doi:10.1016/j.jaip.2023.08.034.

    PMID: 37652348
  99. 99

    Changes in Peripheral Blood Eosinophil Counts and Risk of Eosinophilic Granulomatosis with Polyangiitis Onset after Initiation of Dupilumab Administration in Adult Patients with Asthma.

    Kushima Y, Shimizu Y, Hoshi H, et al.

    Journal of clinical medicine 2023; (12(17)) doi:10.3390/jcm12175721.

    PMID: 37685789
  100. 100

    Inhaled Corticosteroid Exposure and Risk of Cataract in Patients with Asthma and COPD: A Systematic Review and Meta-Analysis.

    Savran O, Suppli Ulrik C

    Journal of ophthalmology 2023; (2023()):8209978 doi:10.1155/2023/8209978.

    PMID: 37899845
  101. 101

    Efficacy and Safety of Biologics for Oral Corticosteroid-Dependent Asthma: A Systematic Review and Network Meta-Analysis.

    Phinyo P, Krikeerati T, Vichara-Anont I, Thongngarm T

    The journal of allergy and clinical immunology. In practice 2024; (12(2)):409-420 doi:10.1016/j.jaip.2023.11.007.

    PMID: 37972921
  102. 102

    Occupational asthma induced by fish exposure.

    Añibarro B, Feijoo L, de Las Cuevas N, Seoane FJ

    Occupational medicine (Oxford, England) 2023; (73(9)):581-583 doi:10.1093/occmed/kqad127.

    PMID: 38016183
  103. 103

    What is the Best Way to Diagnose Possible Asthma Patients with Negative Bronchodilator Reversibility Tests?

    Başa Akdoğan B, Koca Kalkan I, Köycü Buhari G, et al.

    Journal of asthma and allergy 2024; (17()):113-122 doi:10.2147/JAA.S437756.

    PMID: 38410137
  104. 104

    Recent developments in occupational asthma.

    Blouin C, Lemière C

    Current opinion in pulmonary medicine 2024; (30(3)):281-286 doi:10.1097/MCP.0000000000001062.

    PMID: 38415698
  105. 105

    Biologic therapies for severe asthma with persistent type 2 inflammation.

    Chandrasekara S, Wark P

    Australian prescriber 2024; (47(2)):36-42 doi:10.18773/austprescr.2024.015.

    PMID: 38737370
  106. 106

    The relationship of early-life household air pollution with childhood asthma and lung function.

    Dai X, Dharmage SC, Lodge CJ

    European respiratory review : an official journal of the European Respiratory Society 2022; (31(165)) doi:10.1183/16000617.0020-2022.

    PMID: 38743526
  107. 107

    Exploring Definitions and Predictors of Response to Biologics for Severe Asthma.

    Scelo G, Tran TN, Le TT, et al.

    The journal of allergy and clinical immunology. In practice 2024; (12(9)):2347-2361 doi:10.1016/j.jaip.2024.05.016.

    PMID: 38768896
  108. 108

    Cleaning products: Their chemistry, effects on indoor air quality, and implications for human health.

    Salonen H, Salthammer T, Castagnoli E, et al.

    Environment international 2024; (190()):108836 doi:10.1016/j.envint.2024.108836.

    PMID: 38917624
  109. 109

    House dust mite allergen avoidance strategies for the treatment of allergic asthma: A hypothesis-generating meta-analysis.

    van Boven FE, Braunstahl GJ, Arends LR, et al.

    The World Allergy Organization journal 2024; (17(6)):100919 doi:10.1016/j.waojou.2024.100919.

    PMID: 38966606
  110. 110

    Update on Asthma Management Guidelines.

    Dubin S, Patak P, Jung D

    Missouri medicine 2024; (121(5)):364-367.

    PMID: 39421468
  111. 111

    Use of High-Dose Inhaled Corticosteroids and Risk of Corticosteroid-Related Adverse Events in Asthma Findings From the NORDSTAR Cohort.

    von Bülow A, Hansen S, Sandin P, et al.

    The journal of allergy and clinical immunology. In practice 2025; (13(7)):1609-1619.e5 doi:10.1016/j.jaip.2025.01.023.

    PMID: 39900241
  112. 112

    Accurate regulatory classification of chemical respiratory allergens: The case for robust characterisation of causation.

    Pemberton MA, Kimber I

    Regulatory toxicology and pharmacology : RTP 2025; (157()):105785 doi:10.1016/j.yrtph.2025.105785.

    PMID: 39952546
  113. 113

    Profiling Blood Hypereosinophilia in Patients on Dupilumab Treatment for Respiratory Conditions: A Real-Life Snapshot.

    Caminati M, Maule M, Bagnasco D, et al.

    The journal of allergy and clinical immunology. In practice 2025; (13(6)):1367-1374.e4 doi:10.1016/j.jaip.2025.01.040.

    PMID: 39956163
  114. 114

    Complications related to oral corticosteroid use in asthma patients: a retrospective cohort study.

    Lai CC, Chen CH, Wang YH, et al.

    Expert review of clinical pharmacology 2025; (18(4)):225-236 doi:10.1080/17512433.2025.2470834.

    PMID: 39998895
  115. 115

    Exacerbation burden in patients treated as intermittent or mild-persistent asthma using short-acting β2-agonist rescue.

    Lugogo NL, Gilbert IA, Gandhi HN, et al.

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2025; (134(5)):539-547.e1 doi:10.1016/j.anai.2025.02.009.

    PMID: 40010667
  116. 116

    Are There Effective Methods to Reduce Exposure to House Dust Mite Allergens? A Meta-Analysis of Randomized Clinical Trials.

    Sobczak M, Kowal K, Pawliczak R

    International forum of allergy & rhinology 2025; (15(8)):792-802 doi:10.1002/alr.23565.

    PMID: 40089899
  117. 117

    Efficacy of air cleaners to reduce allergic responses to cat: A randomized clinical trial using an environmental exposure chamber.

    Gherasim A, Dietsch F, Odul F, et al.

    Respiratory medicine 2025; (242()):108105 doi:10.1016/j.rmed.2025.108105.

    PMID: 40246248
  118. 118

    Biologic Therapies for Severe Asthma: Current Insights and Future Directions.

    Faria N, Costa MI, Fernandes AL, et al.

    Journal of clinical medicine 2025; (14(9)) doi:10.3390/jcm14093153.

    PMID: 40364184
  119. 119

    Maintenance and Reliever Therapy in Pediatric Asthma: A Concise Review of Recent Evidence-Part I.

    Alharbi R, Alharbi AS

    Pediatric annals 2025; (54(10)):e367-e371 doi:10.3928/19382359-20250828-07.

    PMID: 41060060
  120. 120

    Structured tapering of oral corticosteroids in patients with severe asthma at risk of secondary adrenal insufficiency: a case series.

    Salmerón MC, Carrillo AH, Martinez LM, Kyriakos G

    The Pan African medical journal 2025; (52()):44 doi:10.11604/pamj.2025.52.44.48421.

    PMID: 41393182
  121. 121

    Effects of ICS + LABA Combination Therapy on Asthma Control: An Observational Study in Real-World Settings.

    Han P, Wang L

    Therapeutics and clinical risk management 2026; (22()):547261 doi:10.2147/TCRM.S547261.

    PMID: 41889671
  122. 122

    Current and Emerging Biologic Therapies for Severe Asthma.

    Cazzola M, Matera MG, Ora J, et al.

    Drugs 2026; (86(6)):813-840 doi:10.1007/s40265-026-02310-4.

    PMID: 41904357
  123. 123

    Irritant occupational exposure and specific-IgE sensitisation in the EGEA cohort.

    Migueres N, Dumas O, Boudier A, et al.

    Occupational and environmental medicine 2026; (83(2)):100-106 doi:10.1136/oemed-2025-110266.

    PMID: 42045018
  124. 124

    Reactive airways dysfunction syndrome following acute lithium hydroxide dust exposure at a battery material production plant: a case series of 16 workers.

    Lee CG, Park SH, Park JJ, et al.

    Annals of occupational and environmental medicine 2026; (38()):e17 doi:10.35371/aoem.2026.38.e17.

    PMID: 42427009
  125. 125

    Acute Severe Asthma in the Intensive Care Unit: From Bronchodilators to Extracorporeal Membrane Oxygenation.

    Abedi P, Chupp G, Wilson G, et al.

    Journal of intensive care medicine 2026; 8850666261466238 doi:10.1177/08850666261466238.

    PMID: 42661321
  126. 126

    A study protocol for a randomised controlled trial of two stepwise pharmacological treatment approaches to adult asthma: inhaled corticosteroid/formoterol reliever- versus short-acting β2-agonist reliever-based therapy - Asthma on TRACK.

    Sayers R, Cullen R, Oldfield K, et al.

    ERJ open research 2026; (12(5)) doi:10.1183/23120541.00009-2026.

    PMID: 42707905
  127. 127

    Accuracy of type 2 inflammatory biomarkers to diagnose asthma in adults and children: a meta-analysis of 30 studies with prospective validation in an adult primary care cohort.

    Roy MA, Gronnier M, Désy L, et al.

    The Lancet. Respiratory medicine 2026; doi:10.1016/S2213-2600(26)00228-6.

    PMID: 42743935
  128. 128

    Work-related asthma in stainless steel welders, irritant or allergy?

    Moore VC, Robertson AS, Huntley CC, et al.

    Occupational medicine (Oxford, England) 2026; (76(6)):409-416 doi:10.1093/occmed/kqag068.

    PMID: 42758126